[1]
R. da S. Santos and L. G. de Andrade, “PHARMACEUTICAL ACTIVITY IN THE USE OF FACIAL BOTULINUM TOXIN”, REASE, vol. 8, no. 6, pp. 366–375, Jun. 2022, doi: 10.51891/rease.v8i6.5827.